Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.
about
Tacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantationImmunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution.Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioningHigh day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part IPharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantationHigher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival.Cyclosporine use in hematopoietic stem cell transplantation: pharmacokinetic approach.A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation.Cyclosporine area under the curve after allogeneic hematopoietic stem cell transplantation is an indicator of Epstein-Barr virus DNAemia.Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
P2860
Q26472072-0CA99441-EBDE-4243-A013-D58776F8FD81Q30390179-29029F2C-EBD5-41C6-B627-A10E3E258729Q34598248-9367E96A-B289-470F-B593-A15E1E3D25A3Q34802425-9EF9215E-C3C4-4F45-9873-6838E411BA35Q36728151-313E6B54-A510-4F2E-BC80-25E383CD4A79Q36777485-5D5C5EF4-25C9-4802-B7C5-8EA299AF05F4Q36777599-D2401F9A-FBB3-47F5-BB7F-2CF677389A33Q36980277-621D81AB-A039-49CC-BA91-2B005EF19165Q37038199-D9FE4C34-3854-4A9E-B918-E56718E73BE2Q37038889-4230CF7E-61B2-490C-AC1C-F516F1828E42Q37626049-0B7EA41C-0FA3-40FE-9BFF-6BFF12FD92DDQ38562065-9BE16A09-F144-4E58-9741-45ED21CEFFBBQ40966054-5A9F160F-49E9-4962-8AE4-B4BE448D1CB5Q41031184-069B0349-8DB2-43D5-9400-D759C80207CBQ45356647-80F9A873-D6F2-4A36-A9A0-995FFC91CEA3Q50887405-2081EC16-F6AD-4D24-9A20-73396DE94CC0
P2860
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Association between calcineuri ...... opoietic cell transplantation.
@ast
Association between calcineuri ...... opoietic cell transplantation.
@en
type
label
Association between calcineuri ...... opoietic cell transplantation.
@ast
Association between calcineuri ...... opoietic cell transplantation.
@en
prefLabel
Association between calcineuri ...... opoietic cell transplantation.
@ast
Association between calcineuri ...... opoietic cell transplantation.
@en
P2093
P2860
P50
P1476
Association between calcineuri ...... opoietic cell transplantation.
@en
P2093
Bee K Chua
Marcello Rotta
Mary E D Flowers
Paul J Martin
P2860
P304
P356
10.1016/J.BBMT.2011.08.016
P577
2011-08-26T00:00:00Z